|
||
|
||
| [Home Page] [Previous Menu] [Search] |
B-GT/6: Regulatory and clinical data
(Authors: M. Sneyers and M. Goossens - Last revised:
February 28, 2006
)
Title |
Phase II randomized study of immunotherapy of advanced breast cancer by repeated intramuscular injection of a recombinant vaccinia virus containing sequences coding for human MUC-1 and interleukin-2 (TG1031) comparing two doses levels |
Company or sponsor |
Transgène |
Pharmaceutical study code |
TG1031.02 |
Phase |
II |
Unicenter/multicenter study |
multicenter |
| Clinical data | see table 2 |
Installation |
Universitair Ziekenhuis Gent |
Authorisation procedure |
contained use, first use (see relevant regulation) |
Application number |
SBB 219 98/0433 |
User(s) |
Prof. Dr S. Van Belle |
Receipt date |
04/06/1998 |
Biosafety Council meeting date |
10/07/1998 |
Authorisation date |
06/08/1998 |
Status |
trial completed |
|